Dr. Sardar Alamzaib, MD

Dr. Alamzaib practices at Memorial Hermann Greater Heights Hospital in Houston, Texas, part of Memorial Hermann Health System.

Dr. Alamzaib's NPI, 1609220656, was assigned on April 15, 2016. Dr. Alamzaib graduated from Aga Khan Medical College in 2012. Dr. Alamzaib holds Texas license U5626.

Dr. Alamzaib's primary practice is Memorial Hermann Greater Heights Hospital, at 1635 North Loop West, Houston, TX 77008 in Harris County. The practice phone is (713) 448-6796.

Dr. Alamzaib's primary practice is Memorial Hermann Greater Heights Hospital in Houston, Texas, part of Memorial Hermann Health System. Dr. Alamzaib is also affiliated with Memorial Hermann Sugar Land Hospital. The medical group on file is UT Physicians. Dmand AI also links Dr. Alamzaib to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alamzaib practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Alamzaib's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Alamzaib is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Alamzaib's licenses on file in 3 states: Texas, Florida and Michigan.

CMS data shows 506 Medicare services from Dr. Alamzaib across 4 procedure codes in 2024, for 326 Medicare patients. Medicare paid $14,464 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 326 Medicare patients who saw Dr. Alamzaib in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alamzaib's median patient age at 67, with 54% women.

In 2024, Dr. Alamzaib wrote 119 Medicare Part D claims for 37 patients. 83% of them were for generic drugs. CMS names the drug for 62 of them, across 5 drugs with 11 or more claims each, at $14,708 in total drug cost. In 2023, CMS named 142 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Alamzaib for performance year 2024, reported as part of a group. Dr. Alamzaib accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Alamzaib, published from 2018 to 2023. 2023 was the busiest year, with 7. The most frequent topics are Heart Arrest, Hemorrhage and Myocardial Infarction. Dr. Alamzaib has published most often in Cureus. Dr. Alamzaib's most frequent co-authors are M. Chadi Alraies, MD, Yasar Sattar, MD, MS and Rashid Alhusain.

CMS Open Payments shows 83 general payments to Dr. Alamzaib from 17 drug and device companies from 2018 to 2025. Grants make up the largest share, 70% of the total. Medtronic, Inc. paid the most, $4,369.

Dr. Alamzaib graduated from Aga Khan Medical College in 2012.

Dr. Alamzaib is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.